Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PDLIM3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA552099
Description
Immunogen sequence: WGFRLSGGID FNQPLVITRI TPGSKAAAAN LCPGDVILAI DGFGTESMTH ADAQDRIKAA AHQLCLKIDR GETHLWSPQV SEDGKA Highest antigen sequence identity to the following orthologs: Mouse - 95%, Rat - 94%.
The protein encoded by this gene contains a PDZ domain and a LIM domain, indicating that it may be involved in cytoskeletal assembly. In support of this, the encoded protein has been shown to bind the spectrin-like repeats of alpha-actinin-2 and to colocalize with alpha-actinin-2 at the Z lines of skeletal muscle. This gene is found near a region of chromosome 4 that has been implicated in facioscapulohumeral muscular dystrophy, but this gene does not appear to be involved in the disease. Two transcript variants encoding different isoforms have been found for this gene.
Specifications
PDLIM3 | |
Polyclonal | |
Unconjugated | |
PDLIM3 | |
actinin alpha 2 associated LIM protein; actinin-associated LIM protein; Actn2lp; AI463105; ALP; alpha-actinin-2-associated LIM protein; enigma homolog; PDLIM3; PDZ and LIM domain 3; PDZ and LIM domain protein 3; SK-2 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
27295 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q53GG5 | |
PDLIM3 | |
Recombinant protein corresponding to Human PDLIM3. Recombinant protein control fragment (Product #RP-88638). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction